今天在美国的疱疹论坛上看到有些人在讨论一个刚刚上市的新型外用药，名字叫Viraudx-ColdSore lip balm.这其实是一种治疗口唇疱疹（一型）的唇膏，涂抹后能够有效缩短病程并减少复发。
Google了一下发现了这个产品的信息，是Viradux Research公司研制的一种目前唯一能够治疗并能减少复发的外用药。以下是该公司前天刚刚公布的新闻：
New Options in Herpes TreatmentsViradux Research now has two options in the war against HSV1 and HSV2.
Sydney, NSW -- (SBWIRE) -- 03/15/2013 -- Viradux Research, LTD announced today that it has released to market Viradux-ColdSore (TM) as the only effective anti-herpetic HSV1 treatment currently available based on type-III epidermal transportation compounds. Viraudx-ColdSore lip balm has been shown to speed healing of existing herpetic lesions and prevent the reoccurrence of future outbreaks associated with moderate-to-severe Herpes Simplex Virus (HSV-1) infection.
The decision was based on a 2012 study involving a double-blind, placebo-controlled dose escalation clinical trial enrolling approximately 150. Volunteers were selected with moderate-to-severe HSV-1 infections who were otherwise healthy. The study was designed to evaluate the safety and tolerability of Viradux-AU active components (type-III) and their ability to stimulate the immune system, as well as determine the impact of the compound upon viral shedding, which is considered to be a marker of disease recurrence and transmission.
Viradux also provides a solution to HSV2 (genital) infections in the form of an anti-herpetic crème called Viradux-AU. This has also been shown to reduce symptoms, speed healing and prevent future outbreaks in people with moderate to severe HSV2 infections.
"This work provided proof-of-concept that our specific delivery vehicles are successful in topical, localized therapeutics in the fight against herpes” postdoctoral researcher Alysia Kenburogh said in an October interview in Nature. Kenborogh, the lead author of the paper, went on to describe the viral mortality rates as "unexpectedly high and outside our original estimates". Upon learning that this research had led to the decision to market the product Kenburogh admitted that she felt "proud to know something that was originally pure research with no financial goals had resulted in a new product. Mostly, I am pleased that the HSV positive population will have access to a new and more effective treatment option for this unpleasant infection."
Further information regarding research results, product information, and viral epidemiology can be found at the company's websites:
http://www.viradux.com and
http://www.viradux-coldsore.com.Viradux Website
Viradux ColdSore Website
这个项目是2012年开始研究的，因为是外用药，审批起来也没有口服药、疫苗之类的漫长。看了一下成分里面有茶树油等许多植物精华成分。
该公司也研究了一个针对二型疱疹的软膏叫做Viradux-AU，应该也已经在售。
刚在网上看到已经有电商在卖了，7.49美元一支，貌似还不算贵。不知道怎么能买到国内。香港那位大哥可以在香港打听打听，有没有药店卖？
我在他们的官网上看到有用户留言，好评的多。有兴趣的朋友可以跟踪一下，在国外的朋友不妨试试。如果真能快速愈合并减少复发，那肯定应该比口服伐昔洛韦要好，毕竟是外用药。就算不发病，ML之前沫沫预防传染也挺好啊
我觉得我们的选择会越来越多，大家不要灰心。
此消息版主本人暂未找到官方发布的消息，想要购买的战友请自行判断（此处由版主添加）
